Uterine cancer survival rate is as follows. For localized disease, the five-year survival rate is 95%. For the cancer that has spread to the pelvic region, the rate goes down to about 69 to 70%. For distant metastatic disease, unfortunately, the survival rates go down to 17%. However, for all stages combined, the overall five-year uterine cancer survival rate is about 81%. A relative survival rate means that if the five-year survival rate for a specific stage of endometrial cancer is 90%, it means that the women who have that cancer are on average about 90% as likely to live for these five years after being diagnosed in comparison to women who don’t have that cancer.